Benjamin Matthew Segal MD

Dr. Benjamin M Segal, MD, is the Holtom-Garrett Family Professor of Neurology, and Director of the Multiple Sclerosis Center and Program in Neuroimmunology at the University of Michigan in Ann Arbor. He also serves as a Senior Scholar of the A. Alfred Taubman Medical Research Institute, Director of the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS), co-Chair of the Clinical Neuroimmunology and Brain Tumors study section of the NIH, and Chair of the Scientific Advisory Board, VA Multiple Sclerosis Centers of Excellence-East. He was the Program Chair for the ACTRIMS forum between 2016-2018.

Dr. Segal received his medical degree from Brown University and completed his internship in internal medicine at the University of Chicago and neurology residency at New York Hospital/Weill Medical College of Cornell University. His primary research interests pertain to the immunopathology of multiple sclerosis. Dr. Segal's discoveries have contributed to the understanding of how different types of white blood cells and the chemical messengers that they secrete perpetuate inflammation and mediate tissue injury in the central nervous system during multiple sclerosis and similar diseases.

He has received several distinct awards, such as the Commendation Medal for Excellence from the Public Health Service, the Harry Weaver Junior Faculty Award from the National Multiple Sclerosis Society, and the Stanley Aronson Award for Excellence in the Clinical Neurosciences. In 2014 he was inducted into the University of Michigan League of Research Excellence. Dr. Segal is a member of the American Association of Immunologists, American Academy of Neurology, and the American Neurological Association. For the past 5 years, he has been named in Best Doctors in America.